Evidence map›Paper›PMID 41359232›Full record

SynthesisJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026

Pulsed field ablation and the risk of hemolysis-driven acute kidney injury: a systematic review and meta-analysis.

Gabriel Alves Barbosa, Pavel Osmancik, Charles Karel Martins Santos, Maria Clara Ramos Miranda, Augusto Alves Barbosa, Marek Hozman, Sanghamitra Mohanty, Andrea Natale, Antonio da Silva Menezes Junior

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gabriel Alves Barbosa *Medicine Department, Medical Sciences and Life School, Pontifical Catholic University of Goiás, Goiânia, Goiás, Brazil.ORCID http://orcid.org/0009-0006-1489-7551
Pavel Osmancik *Cardiocenter, University Hospital Kralovske Vinohrady, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-0482-4448
Charles Karel Martins SantosMedicine Department, Medical Sciences and Life School, Pontifical Catholic University of Goiás, Goiânia, Goiás, Brazil.ORCID http://orcid.org/0009-0007-9308-9209
Maria Clara Ramos MirandaMedicine Department, Medical Sciences and Life School, Pontifical Catholic University of Goiás, Goiânia, Goiás, Brazil.ORCID http://orcid.org/0009-0004-8877-3151
Augusto Alves BarbosaMedicine Department, Medical Faculty, Federal University of Goiás, Goiânia, Goiás, Brazil.ORCID http://orcid.org/0009-0005-6408-544X
Marek HozmanCardiocenter, University Hospital Kralovske Vinohrady, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-4111-4218
Sanghamitra MohantyTexas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, United States of America.ORCID http://orcid.org/0000-0001-6601-944X
Andrea NataleTexas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, United States of America.ORCID http://orcid.org/0000-0002-5487-0728
Antonio da Silva Menezes JuniorMedicine Department, Medical Sciences and Life School, Pontifical Catholic University of Goiás, Goiânia, Goiás, Brazil. a.menezes.junior@uol.com.br.ORCID http://orcid.org/0000-0003-1751-5206

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulsed-field ablation (PFA) has emerged as a potentially safer alternative to radiofrequency ablation (RFA). However, recent studies have raised concerns that PFA may induce hemolysis, which could contribute to the development of acute kidney injury (AKI).

methodsThe PubMed, Embase, Scopus, and Cochrane databases were searched for randomized clinical trials (RCTs) and non-RCTs that reported AKI incidence and hemolysis biomarkers after PFA. Random-effects models were used to calculate pooled odds ratio (OR) and mean differences (MDs) with 95% confidence intervals (CIs). Substantial heterogeneity was defined as I

resultsTen studies, including one RCT, comprising a total of 3,843 patients, were included, with 1,859 in the PFA group and 1,994 in the RFA group. In the primary endpoint analysis related to AKI and renal function, no significant differences were found between the PFA and RFA groups, with PFA having a total prevalence of 2.1% (95% CI [0.90; 4.84]). The leave-one-out analysis, specifically the exclusion of one outlier study, led to the comparative results having statistical significance statistical significance (OR 3.70, 95% CI [2.49; 5.51], p = 0.0019; I² = 0%), indicating no heterogeneity, and with the total prevalence increasing to 2.4% (95% CI [0.96; 5.93]). Regarding hemolysis, all evaluated biomarkers were significantly elevated in the PFA group, although with high heterogeneity.

conclusionPFA appears to be associated with a slightly higher risk of AKI than RFA. Renal injury is mostly mild-degree and transient. PFA is associated with significant peri-procedural hemolysis.

Indexed as

Acute Kidney InjuryAtrial FibrillationCatheter AblationHemolysisIrreversible Electroporation TherapyPostoperative ComplicationsBiomarkersComorbidityHumansIncidencePrevalenceRisk AssessmentRisk FactorsTreatment OutcomeBiomarkersAcute kidney injuryAtrial fibrillationHemolysisMeta-analysisPulsed field ablation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.